HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 49, 51100-51106, December 3, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/49/51100    most recent M409080200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jirawatnotai, S. Articles by Kiyokawa, H. Search for Related Content PubMed PubMed Citation Articles by Jirawatnotai, S. Articles by Kiyokawa, H. Social Bookmarking                      What's this?

Cdk4 Is Indispensable for Postnatal Proliferation of the Anterior Pituitary^*

Siwanon Jirawatnotai, Aileen Aziyu, Evan C. Osmundson, David S. Moons, Xianghong Zou, Rhonda D. Kineman, and Hiroaki Kiyokawa¶

From the Departments of Biochemistry and Molecular Genetics and Medicine, University of Illinois College of Medicine, Chicago, Illinois 60607

For proper development and tissue homeostasis, cell cycle progression is controlled by multilayered mechanisms. Recent studies using knock-out mice have shown that animals can develop relatively normally with deficiency for each of the G₁/S-regulatory proteins, D-type and E-type cyclins, cyclin-dependent kinase 4 (Cdk4), and Cdk2. Although Cdk4-null mice show no embryonic lethality, they exhibit specific endocrine phenotypes, i.e. dwarfism, infertility, and diabetes. Here we have demonstrated that Cdk4 plays an essential non-redundant role in postnatal proliferation of the anterior pituitary. Pituitaries from wild-type and Cdk4-null embryos at embryonic day 17.5 are morphologically indistinguishable with similar numbers of cells expressing a proliferating marker, Ki67, and cells expressing a differentiation marker, growth hormone. In contrast, anterior pituitaries of Cdk4-null mice at postnatal 8 weeks are extremely hypoplastic with markedly decreased numbers of Ki67⁺ cells, suggesting impaired cell proliferation. Pituitary hyperplasia induced by transgenic expression of human growth hormone-releasing hormone (GHRH) is significantly diminished in the Cdk4+/– genetic background and completely abrogated in the Cdk4–/– background. Small interfering RNA (siRNA)-mediated knockdown of Cdk4 inhibits GHRH-induced proliferation of GH3 somato/lactotroph cells with restored expression of GHRH receptors. Cdk4 siRNA also inhibits estrogen-dependent cell proliferation in GH3 cells and closely related GH4 cells. In contrast, Cdk6 siRNA does not diminish proliferation of these cells. Furthermore, Cdk4 siRNA does not affect GHRH-induced proliferation of mouse embryonic fibroblasts or estrogen-dependent proliferation of mammary carcinoma MCF-7 cells. Taken together, Cdk4 is dispensable for prenatal development of the pituitary or proliferation of other non-endocrine tissues but indispensable specifically for postnatal proliferation of somato/lactotrophs.

Received for publication, August 9, 2004 , and in revised form, September 20, 2004.

^* This work was supported by National Institutes of Health Grants HD38085 and CA100204 (to H. K.) and by the National Institutes of Health-sponsored Center for Women's Health and Reproduction (U54 HD40093). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Genetics, University of Illinois College of Medicine, 900 S. Ashland Ave., M/C 669, Chicago, IL 60607-7170. Tel.: 312-355-1601; Fax: 312-413-2028; E-mail: kiyokawa{at}uic.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. M. Luque, B. S. Soares, X.-d. Peng, S. Krishnan, J. Cordoba-Chacon, L. A. Frohman, and R. D. Kineman Use of the Metallothionein Promoter-Human Growth Hormone-Releasing Hormone (GHRH) Mouse to Identify Regulatory Pathways that Suppress Pituitary Somatotrope Hyperplasia and Adenoma Formation due to GHRH-Receptor Hyperactivation Endocrinology, July 1, 2009; 150(7): 3177 - 3185. [Abstract] [Full Text] [PDF]

				G. A. Peters, D. D. Seachrist, R. A. Keri, and G. C. Sen The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation PNAS, June 30, 2009; 106(26): 10696 - 10701. [Abstract] [Full Text] [PDF]

				V. Quereda and M. Malumbres Cell cycle control of pituitary development and disease J. Mol. Endocrinol., February 1, 2009; 42(2): 75 - 86. [Abstract] [Full Text] [PDF]

				M. Miller, S. Chen, J. Woodliff, and S. Kansra Curcumin (Diferuloylmethane) Inhibits Cell Proliferation, Induces Apoptosis, and Decreases Hormone Levels and Secretion in Pituitary Tumor Cells Endocrinology, August 1, 2008; 149(8): 4158 - 4167. [Abstract] [Full Text] [PDF]

				V. Chesnokova, S. Zonis, T. Rubinek, R. Yu, A. Ben-Shlomo, K. Kovacs, K. Wawrowsky, and S. Melmed Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth Cancer Res., November 1, 2007; 67(21): 10564 - 10572. [Abstract] [Full Text] [PDF]

				M. C. Korrapati, E. A. Lock, and H. M. Mehendale Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death Am J Physiol Renal Physiol, July 1, 2005; 289(1): F175 - F185. [Abstract] [Full Text] [PDF]

				M. BARBACID, S. ORTEGA, R. SOTILLO, J. ODAJIMA, A. MARTIN, D. SANTAMARIA, P. DUBUS, and M. MALUMBRES Cell Cycle and Cancer: Genetic Analysis of the Role of Cyclin-dependent Kinases Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 233 - 240. [Abstract] [PDF]